Belleau Labs
Back to companies

Legion Health

Seed / Series A

defense-autonomy · Seed

Seed Signal Score
11/25
Team Strength
2/5
Validation Depth
2/5
Novelty
3/5
Market Timing
2/5
Capital Efficiency
2/5

Description

Autonomous medical care

Validation Signals

yc batch

Score Rationale

Legion Health shows minimal verifiable signals for defense tech investment. YC acceptance (2021) is a positive selection filter but without named founders, domain expertise in military medicine, or clear defense customer traction, the team remains unvalidated. The 'autonomous medical care' positioning is vague and appears more aligned with civilian telehealth than DoD priorities; no evidence of SBIR, government contract, or named pilot customer exists, and no recent signals suggest alignment with current defense autonomy initiatives like counter-UAS or contested logistics.
Back to all companies